New advances in Duchenne muscular dystrophy
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
| dc.contributor.author | Ananyan, Edgar | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | |
| dc.contributor.opponent | Szentmiklósi, József | |
| dc.contributor.opponent | Halasi, Barbara Dóra | |
| dc.contributor.opponentdept | Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
| dc.contributor.opponentdept | Általános Orvostudományi Kar::Igazságügyi Orvostani Intézet | |
| dc.date.accessioned | 2024-04-19T10:30:54Z | |
| dc.date.available | 2024-04-19T10:30:54Z | |
| dc.date.created | 2024-02-25 | |
| dc.description.abstract | Duchenne muscular dystrophy (DMD) is a progressive, debilitating disorder that results from a mutation present on the X chromosome, leading to the inability to produce functional dystrophin protein. Progressive tissue damage accumulates with every muscle contraction, caused by the lack of dystrophin, and leads to loss of muscle strength, chronic inflammation, and fibrosis. Current treatment involves administration of corticosteroids and management of cardiac and respiratory symptoms as the disease progresses. However, current treatment only slows down the progression of the disease with significant side effects. Therefore multiple new drugs are undergoing trials to either slow down the symptom progression or treat the underlying cause of the disease. In this thesis, we aim to discuss the efficacy, mode of action, and tolerability of newly emerging treatments that could potentially benefit DMD patients. | |
| dc.description.course | általános orvos | |
| dc.description.courselang | angol | |
| dc.description.degree | egységes, osztatlan | |
| dc.format.extent | 43 | |
| dc.identifier.uri | https://hdl.handle.net/2437/369072 | |
| dc.language.iso | en | |
| dc.rights.access | Hozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében. | |
| dc.subject | DMD | |
| dc.subject | Treatment of Duchenne muscular dystrophy | |
| dc.subject | Current treatment of Duchenne muscular dystrophy | |
| dc.subject | Emerging treatments of Duchenne muscular dystrophy | |
| dc.subject.dspace | Medicine::Pharmacology | |
| dc.title | New advances in Duchenne muscular dystrophy |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- New advances in Duchenne muscular dystrophy.pdf
- Méret:
- 1.15 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Thesis
Engedélyek köteg
1 - 1 (Összesen 1)
Nincs kép
- Név:
- license.txt
- Méret:
- 1.94 KB
- Formátum:
- Item-specific license agreed upon to submission
- Leírás: